FR 190997
Latest Information Update: 18 Jul 2002
Price :
$50 *
At a glance
- Originator Fujisawa
- Developer Fujisawa; Nonindustrial source
- Class
- Mechanism of Action Bradykinin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension; Myocardial infarction
Most Recent Events
- 16 Mar 2000 FR 190997 is being investigated for use in hypertension
- 16 Mar 2000 Preclinical development for Hypertension in Japan (Unknown route)
- 27 Sep 1999 New profile